Published in Scand J Gastroenterol on January 01, 1999
Risk of colorectal cancer seven years after flexible sigmoidoscopy screening: randomised controlled trial. BMJ (2009) 5.69
Colorectal cancer screening. Recommendation statement from the Canadian Task Force on Preventive Health Care. CMAJ (2001) 4.69
Appointments timed in proximity to annual milestones and compliance with screening: randomised controlled trial. BMJ (2008) 1.57
Canadian guidelines for colorectal cancer screening. Can J Gastroenterol (2011) 1.55
Short term outcomes of the first round of a pilot colorectal cancer screening programme with guaiac based faecal occult blood test. Gut (2007) 1.06
Colorectal cancer screening. Recommendation statement from the Canadian task force on preventive health care. Can Fam Physician (2001) 0.99
Colorectal cancer screening: tests, strategies, and perspectives. Front Public Health (2014) 0.99
Reduction of the incidence and mortality of rectal cancer by polypectomy: a prospective cohort study in Haining County. World J Gastroenterol (2002) 0.93
Screening for colon cancer. Cancer Imaging (2006) 0.79
Cancer screening trials: nuts and bolts. Semin Oncol (2010) 0.76
Colorectal Cancer Screening in Average Risk Populations: Evidence Summary. Can J Gastroenterol Hepatol (2016) 0.75
[Staging of colorectal cancer. Official recommendations of the Canadian Study Group on Preventive Medicine]. Can Fam Physician (2001) 0.75
Colorectal cancer screening. Scand J Gastroenterol (1999) 0.75
Is There a Place for Screening Flexible Sigmoidoscopy? Curr Colorectal Cancer Rep (2012) 0.75
Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet (1996) 18.89
Calcium and fibre supplementation in prevention of colorectal adenoma recurrence: a randomised intervention trial. European Cancer Prevention Organisation Study Group. Lancet (2000) 3.26
Choice of management strategy for colorectal cancer based on a diagnostic immunohistochemical test for defective mismatch repair. Gut (1999) 2.68
A controlled, randomized trial of highly selective vagotomy versus selective vagotomy and pyloroplasty in the treatment of duodenal ulcer. Gut (1975) 2.68
Randomized study of biennial screening with a faecal occult blood test: results after nine screening rounds. Scand J Gastroenterol (2004) 2.14
Chronic pilonidal disease: a randomized trial with a complete 3-year follow-up. Br J Surg (1985) 2.13
Repeated screening for colorectal cancer with fecal occult blood test. A prospective randomized study at Funen, Denmark. Scand J Gastroenterol (1989) 2.03
A prospective randomized study of follow-up after radical surgery for colorectal cancer. Br J Surg (1997) 1.87
Microalbuminuria as predictor of increased mortality in elderly people. BMJ (1990) 1.85
To lay open or excise a fistula-in-ano: a randomized trial. Br J Surg (1985) 1.65
Prognostic value of urinary albumin excretion rate and other risk factors in elderly diabetic patients and non-diabetic control subjects surviving the first 5 years after assessment. Diabetologia (1993) 1.64
Variants of squamous cell carcinoma of the anal canal and perianal skin and their relation to human papillomaviruses. Cancer Res (1999) 1.63
Recurrence and survival after mesorectal excision for rectal cancer. Br J Surg (2003) 1.61
Initial mass screening for colorectal cancer with fecal occult blood test. A prospective randomized study at Funen in Denmark. Scand J Gastroenterol (1987) 1.61
Omeprazole and ranitidine in treatment of reflux oesophagitis: double blind comparative trial. Br Med J (Clin Res Ed) (1988) 1.59
Colorectal cancer screening: efficiency and effectiveness. Health Econ (1998) 1.59
Nitrous oxide does not influence operating conditions or postoperative course in colonic surgery. Br J Anaesth (1994) 1.52
Karyotypic characterization of colorectal adenocarcinomas. Genes Chromosomes Cancer (1995) 1.48
Survival of rectal cancer patients in Denmark during 1994-99. Colorectal Dis (2004) 1.42
Amantadine and equine influenza: pharmacology, pharmacokinetics and neurological effects in the horse. Equine Vet J (1997) 1.40
Acute hepatitis and roxithromycin. Lancet (1993) 1.39
[Rectoscopy and Hemoccult II in irritable colon. A prospective study]. Ugeskr Laeger (1990) 1.39
Colorectal adenoma characteristics as predictors of recurrence. Dis Colon Rectum (2004) 1.38
Deletion of 1p36 as a primary chromosomal aberration in intestinal tumorigenesis. Cancer Res (1993) 1.32
Melanocytes in the anal canal epithelium. Histopathology (1991) 1.32
Review of colorectal cancer and its metastases in rodent models: comparative aspects with those in humans. Comp Med (2000) 1.30
Gastric acid secretion and risk of recurrence of duodenal ulcer within six to eight years after truncal vagotomy and drainage. Gut (1974) 1.25
Analysis of screening data: colorectal cancer. Int J Epidemiol (1997) 1.24
Influence of follow-up on health-related quality of life after radical surgery for colorectal cancer. Scand J Gastroenterol (1999) 1.20
The Funen Adenoma Follow-up Study. Incidence and death from colorectal carcinoma in an adenoma surveillance program. Scand J Gastroenterol (1993) 1.19
A randomized surveillance study of patients with pedunculated and small sessile tubular and tubulovillous adenomas. The Funen Adenoma Follow-up Study. Scand J Gastroenterol (1995) 1.16
A prospective multicenter evaluation of new fecal occult blood tests in patients undergoing colonoscopy. Am J Gastroenterol (2000) 1.13
The gastric emptying and small intestinal transit after highly selective vagotomy without drainage and selective vagotomy with pyloroplasty. Scand J Gastroenterol (1973) 1.12
Observer homogeneity in the histologic diagnosis of Helicobacter pylori. Latent class analysis, kappa coefficient, and repeat frequency. Scand J Gastroenterol (1992) 1.10
The Funen Adenoma Follow-Up Study. Characteristics of patients and initial adenomas in relation to severe dysplasia. Scand J Gastroenterol (1993) 1.09
Reversible hepatic steatosis in patients treated with interferon alfa-2a and 5-fluorouracil. Cancer (1995) 1.08
A comparison between the results of truncal and selective vagotomy in patients with duodenal ulcer. Scand J Gastroenterol (1970) 1.08
[Recurrence and survival after conventional low anterior resection for rectal cancer]. Ugeskr Laeger (2001) 1.07
Eight to nine year mortality in known non-insulin dependent diabetics and controls. Kidney Int (1992) 1.07
Relationship between serum gastrin concentrations and gastric acid secretion in duodenal ulcer patients before and after selective and highly selective vagotomy. Scand J Gastroenterol (1973) 1.07
Assessments of clonal composition of colorectal adenomas by FISH analysis of chromosomes 1, 7, 13 and 20. Int J Cancer (2001) 1.07
A comparison of gastric acid secretions after highly selective vagotomy without drainage and selective vagotomy with a pyloroplasty. Scand J Gastroenterol (1972) 1.06
Clonal karyotypic abnormalities in colorectal adenomas: clues to the early genetic events in the adenoma-carcinoma sequence. Genes Chromosomes Cancer (1994) 1.05
Recurrent ulcer 5 1/2--8 years after highly selective vagotomy without drainage and selective vagotomy with pyloroplasty. Scand J Gastroenterol (1980) 1.04
The anal transitional zone. Location and extent. Acta Pathol Microbiol Scand A (1979) 1.04
Diagnostic yield in a biennial Hemoccult-II screening program compared to a once-only screening with flexible sigmoidoscopy and Hemoccult-II. Scand J Gastroenterol (2003) 1.03
Prevention of colorectal cancer: guidelines based on new data. WHO Collaborating Center for the Prevention of Colorectal Cancer. Bull World Health Organ (1995) 1.03
Early complications after low anterior resection for rectal cancer using the EEA stapling device. A prospective trial. Dis Colon Rectum (1987) 1.03
Late complications following operations for cancer of the rectum and anus. Dis Colon Rectum (1975) 1.00
Cytogenetic analysis of colorectal adenomas: karyotypic comparisons of synchronous tumors. Cancer Genet Cytogenet (1998) 1.00
Follow-up after radical surgery for colorectal cancer. Design of a randomized study. Scand J Gastroenterol Suppl (1988) 0.99
Intraepithelial neoplasia in the anal canal. The appearance and relation to genital neoplasia. Acta Pathol Microbiol Immunol Scand A (1986) 0.98
Screening of average-risk individuals for colorectal cancer. WHO Collaborating Centre for the Prevention of Colorectal Cancer. Bull World Health Organ (1990) 0.98
Gastric emptying rate and acid secretion after truncal vagotomy and pyloroplasty for duodenal ulceration. Scand J Gastroenterol (1972) 0.98
The pathology and molecular biology of anal intraepithelial neoplasia: comparisons with cervical and vulvar intraepithelial carcinoma. Int J Colorectal Dis (2001) 0.98
Participation in mass screening for colorectal cancer with fecal occult blood test. Scand J Gastroenterol (1986) 0.97
The pattern of recurrent colorectal cancer in a prospective randomised study and the characteristics of diagnostic tests. Int J Colorectal Dis (1997) 0.97
Microglia and macrophages express tumor necrosis factor receptor p75 following middle cerebral artery occlusion in mice. Neuroscience (2006) 0.97
Polyglycolic acid (Dexon) versus silk for fascial closure of abdominal incisions. Acta Chir Scand (1976) 0.97
Colorectal cancer follow-up. Eur J Surg Oncol (2000) 0.96
The value of the insulin test in predicting recurrence after vagotomy and drainage for duodenal ulcer. Scand J Gastroenterol (1971) 0.95
Omeprazole in the long-term treatment of gastro-oesophageal reflux disease. A double-blind randomized dose-finding study. Scand J Gastroenterol (1995) 0.95
The effect of beta-adrenergic blockade upon gastric acid secretion and gastrin secretion during hypoglycaemia before and after vagotomy. Scand J Gastroenterol (1974) 0.94
A new fecal calprotectin test for colorectal neoplasia. Clinical results and comparison with previous method. Scand J Gastroenterol (2001) 0.94
The stability of the insulin test result after truncal vagotomy and drainage for duodenal ulcer. Scand J Gastroenterol (1971) 0.94
Faecal occult blood testing and colonoscopy in the surveillance of subjects at high risk of colorectal neoplasia. Br J Surg (1995) 0.93
Dysplastic changes in the anal canal epithelium in minor surgical specimens. Acta Pathol Microbiol Scand A (1981) 0.93
Gastric ulcer. II. Surgical treatment. Acta Chir Scand (1973) 0.93
Arthritis and collagenous colitis. Report of a case with concomitant chronic polyarthritis and collagenous colitis. Scand J Rheumatol (1983) 0.92
Bleeding gastric ulcer. Surgical and non-surgical treatment of 225 patients. Scand J Gastroenterol (1972) 0.92
Postoperative radiotherapy in rectosigmoid cancer Dukes' B and C: interim report from a randomized multicentre study. Br J Cancer (1982) 0.92
The scavenger receptor, cysteine-rich domain-containing molecule gp-340 is differentially regulated in epithelial cell lines by phorbol ester. Clin Exp Immunol (2002) 0.90
Upper gastrointestinal cancer in a population-based screening program with fecal occult blood test for colorectal cancer. Scand J Gastroenterol (2002) 0.89
Histochemical characteristics of mucins in the small intestine. A comparative study of normal mucosa, benign epithelial tumours and carcinoma. Histochem J (1979) 0.89
Risk and surveillance of individuals with colorectal polyps. Who Collaborating Centre for the Prevention of Colorectal Cancer. Bull World Health Organ (1990) 0.89
Dietary patterns and the risk of colorectal adenoma recurrence in a European intervention trial. Eur J Cancer Prev (2005) 0.88
Mucin histochemistry of the anal canal epithelium. Studies of normal anal mucosa and mucosa adjacent to carcinoma. Histochem J (1981) 0.88
The expression of p53, Ki-67 and urokinase plasminogen activator receptor in colorectal adenomas with true invasion and pseudoinvasion. APMIS (1999) 0.88